Calls Now Open
2024 ADDF-Harrington + 2025 Harrington Scholar-Innovator Programs
April 16, 2024
Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2024 class of Harrington Scholar-Innovators. The scholar awards will support breakthrough new treatments for heart disease, autoimmune disorders, cancer, infectious disease, inflammation, and rare diseases using small molecule...
Continue Reading
February 08, 2023
In an international, multicenter, pivotal Phase 3 trial, a single under-the-skin injection of a biological drug given to patients within seven days of the onset of COVID-19 symptoms cut the likelihood they needed to be hospitalized in half. Continue Reading
November 22, 2022
Travis Dunckley, PhD, University of Arizona, 2016 ADDF-Harrington Scholar and team have developed a candidate drug they hope may successfully block the development or advancement of Alzheimer’s disease in Down syndrome patients. Continue Reading
October 19, 2022
PIC Therapeutics has closed a $35 million Series A financing round centered around the advancement of its lead asset, a novel therapeutic for advanced metastatic breast cancer. Continue Reading
August 18, 2022
Harrington Scholar developing a universal treatment to prevent and treat influenza A. Continue Reading
August 15, 2022
Licensing IP for SIK Inhibitors to Radius Health Continue Reading
August 09, 2022
Development of an exercise wearable to help personalize exercise and minimize the risks of dementia. Continue Reading
April 12, 2022
Potential clinical trial to investigate use in COVID-19 Continue Reading
February 05, 2022
Chiesi Acquires Pioneering Therapeutic Monoclonal Antibodies Portfolio Against EMAP II as Potential Treatment for PAH Continue Reading
January 24, 2022
Linda and Les Vinney committed $1.25 million to establish the Linda and Les Vinney Scholar Program at Harrington Discovery Institute's Center for Brain Health Medicine, which will support new treatments for patients living with Alzheimer's disease. The gift also creates the Linda and Les Vinney Acceleration Awards, which will... Continue Reading
January 18, 2022
Four Medicines in Clinical Trials and More in the Pipeline Continue Reading